drugset

drugset / Trial / NCT00139035

Effects of Cyclosporine A on Pancreatic Insulin Secretion

NCT00139035 ↗

Phase 4 Completed 16 enrolled University of Oslo School of Pharmacy

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Our primary aim is to investigate if cyclosporine A reduces insulin secretion.

Timeline

Start: 2005-04
Primary completion: 2006-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cyclosporine	Peptide	—	—

Indications